Suchergebnisse - "Hypoglycemia chemically induced"
-
1
Autoren: et al.
Quelle: Martine-Edith, G, Zaremba, N, Divilly, P, Søholm, U, Broadley, M, Baumann, P M, Mahmoudi, Z, Gomes, M, Ali, N, Abbink, E J, de Galan, B, Brøsen, J, Pedersen-Bjergaard, U, Vaag, A A, McCrimmon, R J, Renard, E, Heller, S, Evans, M, Cigler, M, Mader, J K, Amiel, S A, Speight, J, Pouwer, F & Hypo-RESOLVE Consortium 2024, 'Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application', Diabetes Technology and Therapeutics, vol. 26, no. 8, pp. 566-574. https://doi.org/10.1089/dia.2023.0596
Diabetes Technology & Therapeutics, 26, 8, pp. 566-574
2024, 'Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application', Diabetes Technology and Therapeutics, vol. 26, no. 8, pp. 566-574. https://doi.org/10.1089/dia.2023.0596Schlagwörter: Adult, Male, Blood Glucose, Hypo-METRICS, Hypoglycemic Agents/therapeutic use, Hypoglycemia/chemically induced, Fitbit, Hypoglycemia symptoms, Hypoglycemia awareness, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, nocturnal hypoglycemia, Internal Medicine - Radboud University Medical Center, Prospective Studies, sleep tracking, Aged, 2. Zero hunger, Blood Glucose Self-Monitoring, Geriatrics - Radboud University Medical Center, Blood Glucose/analysis, Middle Aged, Awareness, 16. Peace & justice, name=Medical Laboratory Technology, Mobile Applications, Hypoglycemia, 3. Good health, Diabetes and Metabolism, Diabetes Mellitus, Type 1, Type 2/drug therapy, Diabetes Mellitus, Type 2, Insulin/therapeutic use, Type 1/drug therapy, continuous glucose monitoring, Female, Smartphone, name=Endocrinology
Dateibeschreibung: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38512385
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/309511
https://doi.org/10.1089/dia.2023.0596
https://cris.maastrichtuniversity.nl/en/publications/991d276b-3d3e-4c9e-8e4c-987b0e22524a
https://doi.org/10.1089/dia.2023.0596
https://research.vumc.nl/en/publications/2162b531-7c29-4e5c-962e-b7e5a92aacd6
https://pure.amsterdamumc.nl/en/publications/29e075ba-f7a9-4ede-aae2-42177c552373
https://doi.org/10.1089/dia.2023.0596
https://repository.ubn.ru.nl//bitstream/handle/2066/309511/309511.pdf
https://hdl.handle.net/2066/309511
https://kclpure.kcl.ac.uk/ws/files/298388583/Martine-Edith_et_al_Symptoms_Authors_Accepted_MS.docx
https://portal.findresearcher.sdu.dk/da/publications/8a57a1e8-b57a-4750-a84d-8859890a60b2
https://doi.org/10.1089/dia.2023.0596 -
2
Autoren: et al.
Quelle: Syst Rev
Systematic Reviews, Vol 14, Iss 1, Pp 1-11 (2025)Schlagwörter: Adolescent, Short-Acting/therapeutic use, Human/therapeutic use, Hypoglycemic Agents/therapeutic use, Hypoglycemia/chemically induced, Adolescents, Regular human insulins, Meta-Analysis as Topic, Insulin, Regular, Human, Diabetes Mellitus, Protocol, Humans, Hypoglycemic Agents, Insulin, Insulin/analogs & derivatives, Rapid-acting insulin analogues, Child, Children, Regular, Insulin, Short-Acting, Hypoglycemia, Meta-analysis, Type 1 diabetes, Diabetes Mellitus, Type 1, Research Design, Type 1/drug therapy, Medicine, Systematic Reviews as Topic
-
3
Autoren: et al.
Weitere Verfasser: et al.
Quelle: J Clin Endocrinol Metab
Schlagwörter: Male, Blood Glucose, Blood glucose/drug effects, name=Clinical Biochemistry, medical, Insulin-secreting cells/drug effects, Metformin/administration & dosage, 0302 clinical medicine, Insulin-Secreting Cells, Sulfonylureas, Middle aged, Clinical Research Article, KATP channel, Cross-Over Studies, Sulfonylurea compounds/administration & dosage, name=Biochemistry, Type 2 diabetes, Middle Aged, Metformin, Diabetes and Metabolism, Gliclazide, Female, Drug Therapy, Combination, Cross-over studies, Adult, Drug therapy, Combination, Hypoglycemia/chemically induced, R Medicine, NS, Hypoglycemic agents/administration & dosage, 03 medical and health sciences, Bet-cell function, Humans, Hypoglycemic Agents, Sitagliptin phosphate/administration & dosage, Diabetes mellitus, Type 2/drug therapy, Aged, Dipeptidyl-Peptidase IV Inhibitors, Gliclazide/administration & dosage, Sitagliptin Phosphate, Hypoglycemia, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, Dipeptidyl-peptidase IV inhibitors/administration & dosage, name=Endocrinology, DPP4 inhibitors
Dateibeschreibung: application/pdf
-
4
Autoren: et al.
Quelle: American journal of kidney diseases, vol. 83, no. 1, pp. 18-27
Schlagwörter: insulin, Myocardial Infarction, major adverse cardiovascular events, mortality, Hypoglycemia, 3. Good health, Hospitalization, Humans, Diabetes Mellitus, Type 2/complications, Hypoglycemic Agents/adverse effects, Retrospective Studies, Insulin/therapeutic use, Hypoglycemia/chemically induced, Hypoglycemia/epidemiology, Renal Dialysis, Renal Insufficiency/complications, Hemodialysis, type 2 diabetes, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Insulin, Renal Insufficiency
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37657634
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_B10BC32DD44F0
https://serval.unil.ch/resource/serval:BIB_B10BC32DD44F.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_B10BC32DD44F
https://discovery-pp.ucl.ac.uk/id/eprint/10180600/ -
5
Autoren: et al.
Quelle: Davidsen, L, Jensen, M H, Cook, M E, Vestergaard, P, Knop, F K, Drewes, A M & Olesen, S S 2024, 'Metformin Treatment is Associated with Reduced Risk of Hypoglycaemia, Major Adverse Cardiovascular Events, and All-Cause Mortality in Patients with Post-pancreatitis Diabetes Mellitus: A Nationwide Cohort Study', European Journal of Endocrinology, vol. 190, no. 1, pp. 44-53. https://doi.org/10.1093/ejendo/lvad175
Schlagwörter: Adult, treatment, Diabetes Mellitus, Type 2/complications, pancreatitis, Hypoglycemia/chemically induced, Metformin, Hypoglycemia, Hypoglycemic Agents/adverse effects, 3. Good health, Cohort Studies, 03 medical and health sciences, Glucose, 0302 clinical medicine, Diabetes Mellitus, Type 2, Pancreatitis, Cardiovascular Diseases, diabetes mellitus, Pancreatitis/drug therapy, Humans, Hypoglycemic Agents, Cardiovascular Diseases/drug therapy, metformin, Metformin/adverse effects
Dateibeschreibung: application/pdf
-
6
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Alwan, Heba; Ware, Julia; Boughton, Charlotte K; Wilinska, Malgorzata; Allen, Janet M; Lakshman, Rama; Nwokolo, Munachiso; Hartnell, Sara; Bally, Lia; de Beaufort, Carine; Besser, Rachel Elizabeth Jane; Campbell, Fiona; Davis, Nikki; Denver, Louise; Evants, Mark L; Fröhlich-Reiterer, Elke; Ghatak, Atrayee; Hofer, Sabine E; Kapellen, Thomas M; Leelarathna, Lalantha; ... (2023). Time spent in hypoglycemia according to age and time-of-day: Observations during closed-loop insulin delivery. Diabetes technology & therapeutics, 25(7), pp. 485-491. Mary Ann Liebert 10.1089/dia.2023.0061 <http://dx.doi.org/10.1089/dia.2023.0061>
Alwan, H, Ware, J, Boughton, C K, Wilinska, M E, Allen, J M, Lakshman, R, Nwokolo, M, Hartnell, S, Bally, L, de Beaufort, C, Besser, R E J, Campbell, F M, Davis, N, Denvir, L, Evans, M L, Fröhlich-Reiterer, E, Ghatak, A, Hofer, S E, Kapellen, T M, Leelarathna, L, Mader, J K, Narendran, P, Rami-Mehrar, B, Tauschmann, M, Thabit, H, Thankamony, A & Hovorka, R 2023, 'Time Spent in Hypoglycemia According to Age and Time of Day : Observations During Closed-Loop Insulin Delivery', Diabetes technology & therapeutics, vol. 25, no. 7, pp. 485-491. https://doi.org/10.1089/dia.2023.0061Schlagwörter: Blood Glucose, Adult, Adolescent, Diabetes Mellitus, Type 1/drug therapy, Human/therapeutic use, 610 Medicine & health, Hypoglycemic Agents/therapeutic use, Artificial pancreas, Hypoglycemia/chemically induced, Insulin pump therapy, Young Adult, Insulin Infusion Systems, 360 Social problems & social services, Insulin, Regular, Human, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, Closed-loop insulin delivery, Preschool, Child, Regular, Aged, Retrospective Studies, Cross-Over Studies, Middle Aged, Insulin, Regular, Human/therapeutic use, Hypoglycemia, 3. Good health, Insulin/adverse effects, Type 1 diabetes, Diabetes Mellitus, Type 1, Treatment Outcome, Child, Preschool, Type 1/drug therapy, Randomized trial
Dateibeschreibung: application/pdf; application/msword
-
7
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Trials
Trials, Vol 25, Iss 1, Pp 1-15 (2024)
Andriessen, C, Blom, M T, van Hoek, B A C E, de Boer, A W, Denig, P, de Wit, G A, Swart, K, de Rooij-Peek, A, van Marum, R J, Hugtenburg, J G, Slottje, P, van Raalte, D, van Bloemendaal, L, Herings, R, Nijpels, G, Vos, R C & Elders, P J M 2024, 'A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study : the study protocol for a randomised controlled trial', Trials, vol. 25, no. 1, 505. https://doi.org/10.1186/s13063-024-08249-9Schlagwörter: Blood Glucose, Medicine (General), Time Factors, Medicine (miscellaneous), Hypoglycemic Agents/therapeutic use, Glycemic Control, Hypoglycemia/chemically induced, Glycated Hemoglobin/metabolism, Study Protocol, Blood Glucose/drug effects, Elderly, R5-920, Deprescriptions, Patient Education as Topic, Extended normalisation process theory, General practitioners, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, Multicenter Studies as Topic, Pharmacology (medical), Aged, Netherlands, Randomized Controlled Trials as Topic, Glycated Hemoglobin, Sulfonylurea Compounds/therapeutic use, Overtreatment, Patient Education as Topic/methods, Age Factors, Type 2 diabetes, Hypoglycemia, 3. Good health, Sulfonylurea Compounds, Treatment Outcome, Type 2/drug therapy, Diabetes Mellitus, Type 2, Insulin/therapeutic use, Hypoglycaemia, Biomarkers/blood, Biomarkers
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39049109
https://doaj.org/article/cf72caee8a31466bafd4375690a70f20
https://research.vu.nl/en/publications/a419ddac-1e9b-4805-98ca-dbd16ea5a288
https://doi.org/10.1186/s13063-024-08249-9
https://hdl.handle.net/1871.1/a419ddac-1e9b-4805-98ca-dbd16ea5a288
https://research.vumc.nl/en/publications/9e18821d-d595-48f5-a8ca-ee7c67b5b792
https://dspace.library.uu.nl/handle/1874/454878
https://hdl.handle.net/1887/4239214
https://hdl.handle.net/10029/627753 -
8
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Journal of the American Geriatrics Society. 71:2107-2119
Schlagwörter: Male, Blood Glucose, MESH: Diabetes Mellitus, Type 1, MESH: Blood Glucose / analysis, [SHS.PSY]Humanities and Social Sciences/Psychology, MESH: Blood Glucose Self-Monitoring, [SHS.PSY] Humanities and Social Sciences/Psychology, 80 and over, Type 2* / drug therapy, Humans, Insulin, Hypoglycemic Agents, Prospective Studies, Aged, MESH: Aged, Aged, 80 and over, MESH: Humans, Type 2* / complications, Blood Glucose Self-Monitoring, basal insulin analogues, older patients, MESH: Hypoglycemia* / chemically induced, MESH: Male, MESH: Prospective Studies, Hypoglycemia, 3. Good health, MESH: Insulin / adverse effects, hypoglycemia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, glycemic control, continuous glucose monitoring, Female, type 2 diabetes, MESH: Hypoglycemia* / epidemiology, MESH: Hypoglycemic Agents / adverse effects, MESH: Female
Dateibeschreibung: application/pdf
-
9
Autoren: et al.
Quelle: Brøsen, J M B, Agesen, R M, Kristensen, P L, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2023, 'Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia', Diabetes, Obesity and Metabolism, vol. 25, no. 6, pp. 1557-1565. https://doi.org/10.1111/dom.15003
Brøsen, J M B, Agesen, R M, Kristensen, P L, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2023, ' Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia ', Diabetes, Obesity and Metabolism, vol. 25, no. 6, pp. 1557-1565 . https://doi.org/10.1111/dom.15003Schlagwörter: Blood Glucose, type 1 diabetes, insulin analogues, Insulin Glargine, clinical trial, Hypoglycemia/chemically induced, 16. Peace & justice, Insulin Glargine/adverse effects, Hypoglycemia, Hypoglycemic Agents/adverse effects, 3. Good health, 03 medical and health sciences, glycaemic control, Diabetes Mellitus, Type 1, 0302 clinical medicine, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1/drug therapy, Humans, Hypoglycemic Agents, basal insulin, Type 2, hypoglycaemia
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36749303
https://vbn.aau.dk/ws/files/539124056/Diabetes_Obesity_Metabolism_-_2023_-_Br_sen_-_Effect_of_insulin_degludec_versus_insulin_glargine_U100_on_nocturnal.pdf
http://www.scopus.com/inward/record.url?scp=85149986760&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/c728821a-6d2a-4051-b5bf-3b6ae4088b70
https://doi.org/10.1111/dom.15003
https://pure.au.dk/portal/en/publications/b4c6e12a-3785-45a9-90b6-a8524e8d0df2
https://curis.ku.dk/ws/files/359552667/Diabetes_Obesity_Metabolism_2023_Br_sen_Effect_of_insulin_degludec_versus_insulin_glargine_U100_on_nocturnal.pdf
https://portal.findresearcher.sdu.dk/da/publications/e5243aad-3930-4382-9383-564d8de80ea8
https://doi.org/10.1111/dom.15003
http://www.scopus.com/inward/record.url?scp=85149986760&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/b4c6e12a-3785-45a9-90b6-a8524e8d0df2
https://pure.au.dk/ws/files/401315063/Diabetes_Obesity_Metabolism_-_2023_-_Br_sen_-_Effect_of_insulin_degludec_versus_insulin_glargine_U100_on_nocturnal.pdf
https://doi.org/10.1111/dom.15003 -
10
Autoren: et al.
Weitere Verfasser: et al.
Quelle: FLASH-UK Trial Study Group 2022, 'Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes', The New England Journal of Medicine, vol. 387, no. 16, pp. 1477-1487. https://doi.org/10.1056/NEJMoa2205650
Schlagwörter: Adult, Male, Blood Glucose, Glycated Hemoglobin, Blood Glucose Self-Monitoring, Type 1/blood, Diabetes Mellitus, Type 1/blood, Blood Glucose/analysis, Hypoglycemia/chemically induced, Middle Aged, Hypoglycemic Agents/administration & dosage, 16. Peace & justice, Hypoglycemia, 3. Good health, 03 medical and health sciences, Diabetes Mellitus, Type 1, 0302 clinical medicine, Diabetes Mellitus, Glycated Hemoglobin/analysis, Humans, Hypoglycemic Agents, Insulin, Female, Insulin/administration & dosage
Dateibeschreibung: application/octet-stream
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36198143
https://research.manchester.ac.uk/en/publications/6dd84428-6edd-4afc-a308-61d8ffbcce02
https://doi.org/10.1056/NEJMoa2205650
https://www.mendeley.com/catalogue/d4dbc73a-7d8c-3e91-a460-16e0f8c2f02c/
https://research.manchester.ac.uk/en/publications/6dd84428-6edd-4afc-a308-61d8ffbcce02
https://doi.org/10.1056/NEJMoa2205650
http://www.scopus.com/inward/record.url?scp=85140416626&partnerID=8YFLogxK -
11
Autoren: et al.
Quelle: Christensen, M, Laugesen, E L G, Bibby, B M & Hansen, K W 2024, 'The glycaemic roller coaster phenomenon in type 1 diabetes', Diabetes, Obesity and Metabolism, vol. 26, no. 1, pp. 389-391. https://doi.org/10.1111/dom.15297
Schlagwörter: Blood Glucose, Diabetes Mellitus, Type 1, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1/complications, Humans, continuous glucose monitoring, Hypoglycemia/chemically induced, roller coaster, type 1 diabetes mellitus, Hypoglycemia, hypoglycaemia
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37770974
-
12
Autoren: et al.
Quelle: Brøsen, J M B, Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, 'Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654. https://doi.org/10.1089/dia.2021.0567
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Ullits Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Krarup Hansen, T, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Bogh Juhl, C, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567Schlagwörter: Blood Glucose, Glycated Hemoglobin, Blood Glucose Self-Monitoring, Insulin Glargine, Hypoglycemia/chemically induced, Insulin Glargine/adverse effects, Hypoglycemia, Glycated Hemoglobin A/analysis, Hypoglycemic Agents/adverse effects, 3. Good health, Insulin, Long-Acting, 03 medical and health sciences, Type 1 diabetes, Diabetes Mellitus, Type 1, 0302 clinical medicine, Insulin glargine U100, Nocturnal hypoglycemia, Diabetes Mellitus, Type 1/drug therapy, Insulin, Long-Acting, Humans, Hypoglycemic Agents, Insulin analogs, Insulin degludec
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35467938
https://vbn.aau.dk/da/publications/394469f0-d0cf-46d5-b934-7a74a70def56
https://doi.org/10.1089/dia.2021.0567
https://vbn.aau.dk/ws/files/486633938/dia.2021.0567.pdf
http://www.scopus.com/inward/record.url?scp=85137135528&partnerID=8YFLogxK
https://curis.ku.dk/ws/files/320655164/dia.2021.0567.pdf
https://portal.findresearcher.sdu.dk/da/publications/9395c469-d35a-47f5-b698-2a8411063e9c
https://doi.org/10.1089/dia.2021.0567 -
13
Autoren: et al.
Quelle: Diabetes Obes Metab
Diabetes, obesity & metabolism, vol. 24, no. 11, pp. 2102-2107Schlagwörter: Blood Glucose, Glycated Hemoglobin, 03 medical and health sciences, Diabetes Mellitus, Type 1, Glucose, 0302 clinical medicine, Blood Glucose Self-Monitoring, Humans, Hypoglycemia/chemically induced, Hypoglycemia/epidemiology, FreeStyle Libre, blood glucose monitoring, diabetes, glucose variability, real life data, Original Articles, Hypoglycemia
Dateibeschreibung: application/pdf
-
14
Autoren: et al.
Quelle: Canadian Journal of Diabetes. 46:473-479
Schlagwörter: 0301 basic medicine, type 2 diabetes mellitus, Hypoglycemia/chemically induced, Hypoglycemia, Hypoglycemic Agents/adverse effects, 3. Good health, antihyperglycemics, 03 medical and health sciences, Deprescriptions, 0302 clinical medicine, deprescribing, Type 2/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Humans, Hypoglycemic Agents, older adults, Aged, Retrospective Studies
-
15
Autoren: et al.
Quelle: Verhulst, C E M, van Heck, J I P, Fabricius, T W, Stienstra, R, Teerenstra, S, McCrimmon, R J, Tack, C J, Pedersen-Bjergaard, U, de Galan, B E & Hypo-RESOLVE Consortium 2024, 'The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode', Cardiovascular Diabetology, vol. 23, no. 1, 55. https://doi.org/10.1186/s12933-023-02095-w
Schlagwörter: Antecedent hypoglycaemia, Clamp, Diabetes, Humans, Inflammatory responses, Blood Glucose/metabolism, C-Reactive Protein, Hypoglycemia/chemically induced diagnosis, Epinephrine, Insulin, Hypoglycemic Agents/adverse effects, Diabetes Mellitus, Type 1
Relation: info:eu-repo/semantics/altIdentifier/pissn/1475-2840
-
16
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Diabet Med
Diabetic Medicine, 37, 6, pp. 1066-1073
Diabetic medicine, vol. 37, no. 6, pp. 1066-1073
de Galan, B E, McCrimmon, R J, Ibberson, M, Heller, S R, Choudhary, P, Pouwer, F, Speight, J, Carlton, J, Pieber, T R, Rosilio, M, Tack, C J, Müllenborn, M & Hypo-RESOLVE Consortium 2020, ' Reducing the burden of hypoglycaemia in people with diabetes through increased understanding : design of the Hypoglycaemia Redefining Solutions for Better Lives (Hypo-RESOLVE) project ', Diabetic Medicine, vol. 37, no. 6, pp. 1066-1073 . https://doi.org/10.1111/dme.14240
Diabetic MedicineSchlagwörter: Databases, Factual, onset, intensive glucose control, FEAR, name=Internal Medicine, 03 medical and health sciences, 0302 clinical medicine, Cost of Illness, Risk Factors, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, Internal Medicine - Radboud University Medical Center, Mortality, Diabetes Mellitus/drug therapy, Health Care Costs, Hypoglycemia/chemically induced, Hypoglycemia/economics, Hypoglycemia/physiopathology, Hypoglycemia/psychology, Hypoglycemic Agents/adverse effects, Insulin/adverse effects, Research Articles, association, ASSOCIATION, INTENSIVE GLUCOSE CONTROL, Hypoglycemia, 3. Good health, Diabetes and Metabolism, ONSET, fear, Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences, name=Endocrinology
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/31970814
https://eprints.whiterose.ac.uk/157236/1/Galan_et_al-2020-Diabetic_Medicine.pdf
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/220541
https://doi.org/10.1111/dme.14240
https://cris.maastrichtuniversity.nl/en/publications/7694645a-74f2-49d4-a575-d8eeb385d92a
https://doi.org/10.1111/dme.14240
https://www.ncbi.nlm.nih.gov/pubmed/31970814
https://discovery.dundee.ac.uk/en/publications/reducing-the-burden-of-hypoglycaemia-in-people-with-diabetes-thro
https://pubmed.ncbi.nlm.nih.gov/31970814/
https://cris.maastrichtuniversity.nl/en/publications/reducing-the-burden-of-hypoglycaemia-in-people-with-diabetes-thro
https://onlinelibrary.wiley.com/doi/epdf/10.1111/dme.14240
https://repository.ubn.ru.nl/handle/2066/220541
https://repository.ubn.ru.nl//bitstream/handle/2066/220541/220541.pdf
https://hdl.handle.net/2066/220541
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_942699F55E735
https://serval.unil.ch/notice/serval:BIB_942699F55E73
https://serval.unil.ch/resource/serval:BIB_942699F55E73.P001/REF.pdf
https://findresearcher.sdu.dk:8443/ws/files/169076907/dme.14240.pdf
https://portal.findresearcher.sdu.dk/da/publications/735006b0-41ba-4d4c-8cda-56eef5f23ada
https://doi.org/10.1111/dme.14240 -
17
Autoren: et al.
Quelle: EMBO reports, vol. 24, no. 8, pp. e57344
Schlagwörter: Mice, Male, Female, Animals, Glucagon/adverse effects, Calcium, Hypoglycemia/genetics, Hypoglycemia/chemically induced, Vasopressins/adverse effects, Glucose, Neurons/physiology, Blood Glucose, Insulin, Tmem117, counterregulation, glucagon, hypoglycemia, vasopressin
Dateibeschreibung: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/37314252; info:eu-repo/semantics/altIdentifier/eissn/1469-3178; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A52AA25ED9E04; https://serval.unil.ch/notice/serval:BIB_A52AA25ED9E0; https://serval.unil.ch/resource/serval:BIB_A52AA25ED9E0.P001/REF.pdf
-
18
Autoren: et al.
Weitere Verfasser: et al.
Schlagwörter: Aged, Blood Glucose/analysis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/etiology, Cholesterol/blood, Diabetes Mellitus, Type 2/complications, Type 2/drug therapy, Double-Blind Method, Drug Therapy, Combination, Fasting, Fatty Acids, Omega-3/therapeutic use, Female, Follow-Up Studies, Glucose Intolerance/complications, Glucose Intolerance/drug therapy, Hospitalization, Humans, Hypoglycemia/chemically induced, Hypoglycemic Agents/adverse effects, Hypoglycemic Agents/therapeutic use, Incidence, Insulin, Long-Acting/adverse effects, Long-Acting/therapeutic use, Intention to Treat Analysis, Male, Middle Aged
Relation: New England Journal of Medicine; https://iris.unil.ch/handle/iris/95705; serval:BIB_24F963809D9F; 000306738300006
-
19
Autoren: et al.
Schlagwörter: Adenosine Triphosphate/metabolism, Adult, Blood Glucose/metabolism, Brain/metabolism, Energy Metabolism/physiology, Glucose, Homeostasis/physiology, Humans, Hyperglycemia/chemically induced, Hyperglycemia/metabolism, Hypoglycemia/chemically induced, Hypoglycemia/metabolism, Insulin/blood, Lactates/blood, Magnetic Resonance Spectroscopy, Male, Muscle, Skeletal/metabolism
Relation: American Journal of Physiology - Regulatory, Integrative and Comparative Physiology; https://iris.unil.ch/handle/iris/79148; serval:BIB_3C0F31D253A7; 000252243800002
-
20
Autoren: et al.
Schlagwörter: Administration, Oral *Adverse Drug Reaction Reporting Systems Diabetes Mellitus, Type 2/*drug therapy/epidemiology Drug Interactions Drug Monitoring Humans Hypoglycemia/*chemically induced Hypoglycemic Agents/administration & dosage/*adverse effects Prevalence Risk Factors
Relation: Annales de Medecine Interne; https://iris.unil.ch/handle/iris/59398; serval:BIB_2C47EB264F24; A1992HM10400003; 1605454
Verfügbarkeit: https://iris.unil.ch/handle/iris/59398
Nájsť tento článok vo Web of Science 
Full Text 
Full Text Finder